Loading
PA
ProstaLund AB Stock: price and insider trades · Sweden
ProstaLund AB: what insiders have been doing
ProstaLund AB, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finansinspektionen. From 18 October 2025 to 18 October 2026, the disclosure feed for ProstaLund AB logged 2 filings by 1 insider.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Over the last twelve months, not one insider purchase of ProstaLund AB stock was filed.
Across the 890 companies tracked on its exchange, the median is 7 filings; at 2 filings, this issuer sits below that mark. Since 2025, the database holds no purchases and 1 sale by insiders of the company.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€4,309
1 ops. · all time
Who traded when
BuySaleMats Alyhr1 sale
Financial data
· cache
Last declaration on 31 October 2025
Declarations4 total
221,938 shares@ SEK 0.2042.0% of flowAktieISIN SE0002372318FI:A003T257-2
70,515 shares@ SEK 0.2013.4% of flowAktieISIN SE0002372318FI:A003T258-1
2,500,000 shares@ SEK 0.20100.0% of flowAktieISIN SE0002372318FI:A003Q709-1
52,783 shares@ SEK 0.911544.6% of flowAktieISIN SE0002372318FI:A003Q500-1
4 of 4 declarations
About ProstaLund AB
ProstaLund AB is a company focused on developing treatments for prostate disorders. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
